Media contact: Anne DeLotto Baier, USF Health Sciences Public Affairs, (813) 974-3300 or abaier@hsc.usf.edu
USF and Byrd Institute designated
Tampa, FL (May 10, 2005) -- The University of South Florida, in collaboration with the Johnnie B. Byrd Sr. Alzheimer's
The grant from the National Institute on Aging, part of the National Institutes of Health, will support comprehensive Alzheimer's research projects focusing on understanding the disease's destructive progression through the human mind and on core facilities to assess Alzheimer's disease in patients.
The ADRC designation validates the national prominence of USF and its affiliates in the field of Alzheimer's education, research and patient care, said
"This is the highest award that the NIA gives – more significant than any single research award," said
In the current round of NIA funding, USF was one of only 13 institutions across the country receiving the ADRC grant.
USF will work with the Byrd Institute and other partners, including
"We are excited that the
Submitted by USF, the application for ADRC advanced through a two-tier peer-review process and scored very well, ensuring
The Byrd Institute will coordinate the multi-site ADRC, including computerized databases, videoconferencing facilities and MRI procedures for all subjects in the Clinical Core, and will underwrite much of the administrative structure and personnel costs.
"The extensive effort and cooperation required to establish an ADRC in
The center is especially important to Floridians, Dr. Potter said, because the state has the nation's second-highest number of people with Alzheimer's disease. An estimated 430,000 Floridians suffer from Alzheimer's.
In addition to Dr. Potter and Dr. Pfeiffer, other USF researchers participating in the ADRC grant include Gary Arendash, PhD; William Haley, PhD; David Morgan, PhD; James Mortimer, PhD; and Yougui Wu, PhD.
The ADRC at USF and Byrd Institute will support 3 comprehensive research projects to:
- Better understand the transition from mild memory loss to Alzheimer's disease and find ways to identify those at high risk of developing Alzheimer's.
· Use mouse models to study how stimulating environments might slow or reverse cognitive impairment.
· Investigate early cognitive rehabilitation approaches to slow disease progression in patients.
-USF-
The

